WIDAPLIK™, a newly FDA-approved triple combo pill, promises better blood pressure control for adults, including those starting hypertension treatment for the first time.

George Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill combination treatment for hypertension in adults, including initial treatment ...

WIDAPLIK is a proprietary single pill combination of three medicines: telmisartan, amlodipine and indapamide and is available in three doses: a standard dose and two low doses. It is the first and ...

WIDAPLIK is a combination tablet of telmisartan, an angiotensin II receptor blocker, amlodipine, a dihydropyridine calcium channel blocker and indapamide, a thiazide-like diuretic, available in ...

WIDAPLIK is a proprietary single pill combination of three medicines: telmisartan, amlodipine and indapamide and is available in three doses: a standard dose and two low doses.

WIDAPLIK is a proprietary single pill combination of three medicines: telmisartan, amlodipine and indapamide and is available in three doses: a standard dose and two low doses. It is the first and ...

The Food and Drug Administration (FDA) has approved Widaplik ™ (telmisartan, amlodipine and indapamide), a single pill combination therapy, for the treatment of hypertension, including as ...

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.

The drug combines established high blood pressure meds telmisartan, amlodipine and indapamide and is the first triple-combination therapy to boast a label from the FDA that allows its use as an ...

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

The US Food and Drug Administration approved a triple therapy polypill for the treatment of patients with hypertension, manufacturer George Medicines announced yesterday. The single pill (Widaplik), ...